HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sign language in childhood epileptic aphasia (Landau-Kleffner syndrome).

Abstract
Acquired epileptic aphasia (AEA, or Landau-Kleffner syndrome) is a unique condition in which children can lose oral language (OL) comprehension and expression for a prolonged period. These children can benefit from visual forms of language, mainly sign language (SL), but the quality of SL has never been analyzed. The case is reported here of a boy with AEA who lost speech comprehension and expression from 3 years 6 months to 7 years and was educated in SL from the age of 6 years. His SL was evaluated at the age of 13 years and 6 months and compared with a control child with congenital sensorineural deafness. It was found that: (1) our patient achieved the same proficiency in SL as the control child with deafness; (2) SL learning did not compete with, but perhaps even hastened, the recovery of OL. Intact ability to learn a new linguistic code such as SL suggests that higher-order language areas were preserved and received input from a separate visual route, as shown by neuropsychological and functional imaging research in deaf and hearing signers.
AuthorsE R Perez, V Davidoff
JournalDevelopmental medicine and child neurology (Dev Med Child Neurol) Vol. 43 Issue 11 Pg. 739-44 (Nov 2001) ISSN: 0012-1622 [Print] England
PMID11730147 (Publication Type: Case Reports, Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Hearing Loss, Sensorineural (congenital, diagnosis)
  • Humans
  • Landau-Kleffner Syndrome (diagnosis)
  • Language Disorders (diagnosis, therapy)
  • Language Tests
  • Male
  • Photic Stimulation
  • Recovery of Function
  • Sign Language
  • Speech Discrimination Tests
  • Verbal Behavior

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: